2022. Royal jelly significantly alters inflammasome pathways in patients with chronic hepatitis B. Indian Journal of Experimental Biology (IJEB). 60, 11 (Oct. 2022), 875–879. DOI:https://doi.org/10.56042/ijeb.v60i11.60264.